These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 6152684

  • 1. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV.
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract] [Full Text] [Related]

  • 2. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE, McCartan D, White J, King DJ.
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract] [Full Text] [Related]

  • 3. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E.
    Behav Brain Res; 2010 Jun 26; 210(1):99-106. PubMed ID: 20156489
    [Abstract] [Full Text] [Related]

  • 4. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J.
    J Clin Psychopharmacol; 2008 Jun 26; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [Abstract] [Full Text] [Related]

  • 5. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A.
    Behav Brain Res; 2006 Feb 28; 167(2):379-82. PubMed ID: 16246436
    [Abstract] [Full Text] [Related]

  • 6. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.
    Psychiatr Pol; 2009 Feb 28; 43(2):183-92. PubMed ID: 19697788
    [Abstract] [Full Text] [Related]

  • 7. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychopharmacol; 2008 Jun 28; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [Abstract] [Full Text] [Related]

  • 8. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK.
    Psychopharmacol Bull; 1985 Jun 28; 21(2):216-21. PubMed ID: 2860692
    [No Abstract] [Full Text] [Related]

  • 9. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
    Airaksinen E, Airaksinen MM.
    Duodecim; 2003 Jun 28; 119(16):1553-62. PubMed ID: 14535028
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF.
    J Clin Psychiatry; 2006 Jan 30; 67 Suppl 8():7-12. PubMed ID: 16961424
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA, Dépatie L, Holahan AL, Savion-Lemieux T, Barr RG, Jolicoeur C, Douglas VI.
    Biol Psychiatry; 2005 Jun 01; 57(11):1452-60. PubMed ID: 15950020
    [Abstract] [Full Text] [Related]

  • 16. Treating problem children with stimulant drugs.
    Sroufe LA, Stewart MA.
    N Engl J Med; 1973 Aug 23; 289(8):407-13. PubMed ID: 4146358
    [No Abstract] [Full Text] [Related]

  • 17. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):34-41. PubMed ID: 17714843
    [Abstract] [Full Text] [Related]

  • 18. Drug therapies for attentional disorders alter the signal-to-noise ratio in the superior colliculus.
    Dommett EJ, Overton PG, Greenfield SA.
    Neuroscience; 2009 Dec 15; 164(3):1369-76. PubMed ID: 19747530
    [Abstract] [Full Text] [Related]

  • 19. Adolescent and adult male spontaneous hyperactive rats (SHR) respond differently to acute and chronic methylphenidate (Ritalin).
    Barron E, Yang PB, Swann AC, Dafny N.
    Int J Neurosci; 2009 Dec 15; 119(1):40-58. PubMed ID: 19116830
    [Abstract] [Full Text] [Related]

  • 20. Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate.
    Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier PM, Hebebrand J, Remschmidt H.
    Eur Child Adolesc Psychiatry; 2004 Apr 15; 13(2):100-4. PubMed ID: 15103535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.